< 生产厂家价格 >

1,3-二丙基-8-p-硫化苯基黄嘌呤

1,3-二丙基-8-p-硫化苯基黄嘌呤名称

[ CAS 号 ]:
89073-57-4

[ 中文名 ]:
1,3-二丙基-8-p-硫化苯基黄嘌呤

[ 英文名 ]:
1,3-DIPROPYL-8-P-SULFOPHENYLXANTHINE

[中文别名 ]:

[英文别名 ]:

1,3-Dspx
DPSPX
PSPX
1,3-Dipropyl-8-(p-sulfophenyl)xanthine
MFCD00055080

1,3-二丙基-8-p-硫化苯基黄嘌呤物理化学性质

[ 密度 ]:
1.405g/cm3

[ 熔点 ]:
>300ºC

[ 分子式 ]:
C₁₇H₂₀N₄O₅S

[ 分子量 ]:
392.43000

[ 精确质量 ]:
392.11500

[ PSA ]:
135.43000

[ LogP ]:
2.70080

[ 折射率 ]:
1.607

1,3-二丙基-8-p-硫化苯基黄嘌呤安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ 安全声明 (欧洲) ]:
S22-S24/25

[ 危险品运输编码 ]:
NONH for all modes of transport

[ 海关编码 ]:
2933990090

1,3-二丙基-8-p-硫化苯基黄嘌呤合成路线

详细合成路线

1,3-二丙基-8-p-硫化苯基黄嘌呤上下游产品

1,3-二丙基-8-p-硫化苯基黄嘌呤上游产品

1,3-二丙基-8-p-硫化苯基黄嘌呤下游产品

1,3-二丙基-8-p-硫化苯基黄嘌呤海关

[ 海关编码 ]: 2933990090

[ 中文概述 ]:
2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

1,3-二丙基-8-p-硫化苯基黄嘌呤文献

Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.

Am. J. Physiol. Renal Physiol. 304(1) , F49-55, (2013)

In a previous study, we demonstrated that human proximal tubular epithelial cells obtained from a commercial source metabolized extracellular 2',3'-cAMP to 2'-AMP and 3'-AMP and extracellular 2'-AMP a...

Expression of the 2',3'-cAMP-adenosine pathway in astrocytes and microglia.

J. Neurochem. 118 , 979-987, (2011)

Many organs express the extracellular 3',5'-cAMP-adenosine pathway (conversion of extracellular 3',5'-cAMP to 5'-AMP and 5'-AMP to adenosine). Some organs release 2',3'-cAMP (isomer of 3',5'-cAMP) and...

Sustained reduction in myocardial reperfusion injury with an adenosine receptor antagonist: possible role of the neutrophil chemoattractant response.

J. Pharmacol. Exp. Ther. 292(3) , 929-38, (2000)

Recent studies have demonstrated that three membrane-permeant A(1) receptor antagonists reduced infarct size in a model of ischemia followed by brief reperfusion. However, it was not determined whethe...

更多文献